Commonwealth Equity Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.7M | Buy |
16,385
+263
| +2% | +$201K | 0.02% | 763 |
|
|
2025
Q4 | $12.4M | Sell |
16,122
-12
| -0.1% | -$8.15K | 0.02% | 784 |
|
|
2025
Q3 | $9.07M | Sell |
16,134
-1,621
| -9% | -$917K | 0.01% | 971 |
|
|
2025
Q2 | $9.32M | Sell |
17,755
-664
| -4% | -$371K | 0.01% | 957 |
|
|
2025
Q1 | $11.7M | Buy |
18,419
+405
| +2% | +$279K | 0.02% | 780 |
|
|
2024
Q4 | $12.8M | Sell |
18,014
-967
| -5% | -$812K | 0.02% | 705 |
|
|
2024
Q3 | $20M | Sell |
18,981
-1,171
| -6% | -$1.3M | 0.03% | 519 |
|
|
2024
Q2 | $21.2M | Buy |
20,152
+780
| +4% | +$756K | 0.03% | 480 |
|
|
2024
Q1 | $18.6M | Buy |
19,372
+526
| +3% | +$500K | 0.03% | 516 |
|
|
2023
Q4 | $16.6M | Buy |
18,846
+508
| +3% | +$418K | 0.03% | 521 |
|
|
2023
Q3 | $15.1M | Sell |
18,338
-64
| -0.3% | -$50.3K | 0.03% | 516 |
|
|
2023
Q2 | $13.2M | Sell |
18,402
-2,254
| -11% | -$1.74M | 0.03% | 571 |
|
|
2023
Q1 | $17K | Buy |
20,656
+183
| +0.9% | +$138K | 0.04% | 451 |
|
|
2022
Q4 | $14.8M | Buy |
20,473
+3,600
| +21% | +$2.66M | 0.04% | 480 |
|
|
2022
Q3 | $11.6M | Sell |
16,873
-820
| -5% | -$516K | 0.03% | 518 |
|
|
2022
Q2 | $10.5M | Buy |
17,693
+1,551
| +10% | +$1.01M | 0.03% | 564 |
|
|
2022
Q1 | $11.3M | Sell |
16,142
-6,025
| -27% | -$3.81M | 0.03% | 574 |
|
|
2021
Q4 | $14M | Sell |
22,167
-1,867
| -8% | -$1.15M | 0.03% | 480 |
|
|
2021
Q3 | $14.5M | Buy |
24,034
+7,628
| +46% | +$4.74M | 0.04% | 435 |
|
|
2021
Q2 | $9.16M | Buy |
16,406
+2,200
| +15% | +$1.11M | 0.02% | 591 |
|
|
2021
Q1 | $6.72M | Buy |
14,206
+2,390
| +20% | +$1.16M | 0.02% | 652 |
|
|
2020
Q4 | $5.71M | Sell |
11,816
-392
| -3% | -$212K | 0.02% | 667 |
|
|
2020
Q3 | $6.83M | Sell |
12,208
-596
| -5% | -$361K | 0.02% | 552 |
|
|
2020
Q2 | $7.99M | Buy |
12,804
+1,921
| +18% | +$1.09M | 0.03% | 478 |
|
|
2020
Q1 | $5.31M | Buy |
10,883
+1,413
| +15% | +$583K | 0.02% | 530 |
|
|
2019
Q4 | $3.56M | Sell |
9,470
-527
| -5% | -$177K | 0.01% | 748 |
|
|
2019
Q3 | $2.77M | Buy |
9,997
+416
| +4% | +$123K | 0.01% | 808 |
|
|
2019
Q2 | $3M | Buy |
9,581
+726
| +8% | +$242K | 0.01% | 763 |
|
|
2019
Q1 | $3.64M | Sell |
8,855
-80
| -0.9% | -$32.9K | 0.02% | 666 |
|
|
2018
Q4 | $3.34M | Buy |
8,935
+997
| +13% | +$365K | 0.02% | 635 |
|
|
2018
Q3 | $3.21M | Buy |
7,938
+1,481
| +23% | +$564K | 0.02% | 691 |
|
|
2018
Q2 | $2.23M | Buy |
6,457
+771
| +14% | +$241K | 0.01% | 849 |
|
|
2018
Q1 | $1.96M | Buy |
5,686
+427
| +8% | +$149K | 0.01% | 876 |
|
|
2017
Q4 | $1.98M | Buy |
5,259
+158
| +3% | +$64K | 0.01% | 860 |
|
|
2017
Q3 | $2.28M | Buy |
5,101
+162
| +3% | +$77.1K | 0.01% | 743 |
|
|
2017
Q2 | $2.43M | Sell |
4,939
-717
| -13% | -$314K | 0.02% | 684 |
|
|
2017
Q1 | $2.19M | Buy |
5,656
+633
| +13% | +$235K | 0.01% | 699 |
|
|
2016
Q4 | $1.84M | Sell |
5,023
-42
| -0.8% | -$16K | 0.01% | 737 |
|
|
2016
Q3 | $2.04M | Buy |
5,065
+59
| +1% | +$23.7K | 0.02% | 675 |
|
|
2016
Q2 | $1.75M | Buy |
5,006
+695
| +16% | +$268K | 0.01% | 710 |
|
|
2016
Q1 | $1.55M | Buy |
4,311
+2
| +0% | +$824 | 0.01% | 746 |
|
|
2015
Q4 | $2.34M | Buy |
4,309
+39
| +0.9% | +$21.1K | 0.02% | 565 |
|
|
2015
Q3 | $1.99M | Sell |
4,270
-8
| -0.2% | -$4.3K | 0.02% | 601 |
|
|
2015
Q2 | $2.18M | Sell |
4,278
-529
| -11% | -$258K | 0.02% | 592 |
|
|
2015
Q1 | $2.17M | Sell |
4,807
-734
| -13% | -$311K | 0.02% | 572 |
|
|
2014
Q4 | $2.27M | Buy |
5,541
+1,422
| +35% | +$559K | 0.03% | 526 |
|
|
2014
Q3 | $1.49M | Buy |
4,119
+125
| +3% | +$41.9K | 0.02% | 666 |
|
|
2014
Q2 | $1.13M | Sell |
3,994
-961
| -19% | -$285K | 0.01% | 806 |
|
|
2014
Q1 | $1.49M | Buy |
4,955
+763
| +18% | +$235K | 0.02% | 626 |
|
|
2013
Q4 | $1.15M | Buy |
4,192
+213
| +5% | +$61.3K | 0.02% | 697 |
|
|
2013
Q3 | $1.25M | Buy |
3,979
+847
| +27% | +$223K | 0.02% | 622 |
|
|
2013
Q2 | $704K | Buy |
+3,132
| New | +$729K | 0.01% | 855 |
|
Other funds holding REGN
VCM
N
Commonwealth Equity Services's REGN Position: Q1 2026 in Review
Commonwealth Equity Services increased its Regeneron Pharmaceuticals (REGN) stake by 1.6% in Q1 2026, buying an estimated $201K and bringing the position to 16,385 shares worth $12.7M. The position accounts for 0.02% of the portfolio, ranked #763.
Commonwealth Equity Services first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $21.2M in Q2 2024. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Commonwealth Equity Services held 16,385 shares of Regeneron Pharmaceuticals worth $12.7M as of Q1 2026.
- Commonwealth Equity Services bought 263 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $201K.
- Regeneron Pharmaceuticals made up 0.02% of Commonwealth Equity Services's portfolio in Q1 2026, its #763 holding.
- Commonwealth Equity Services first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Commonwealth Equity Services's Regeneron Pharmaceuticals position peaked at $21.2M in Q2 2024.
- 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.